Rossitto Erica sold $1.8M of HCA

Rossitto Erica (SVP & Chief Nurse Executive) sold 3,500 shares of HCA Healthcare, Inc. (HCA) at $505.81 ($1.77M total) on 2026-11-10.

Original reporting
SEC EDGAR · Rossitto Erica
Published Nov 10, 2026, 10:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 10:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HCA
Bearish
medium confidence
Mentioned
$HCA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HCABearishLow
01

Why it matters

The disclosed sale reduces the insider's holding, which may be interpreted by the market as a mild negative signal.

02

Market read

Provides fresh insider transaction data for HCA, useful for short-term sentiment assessment.

03

What to watch

Potential upcoming earnings or corporate actions not disclosed could contextualize the sale.

Relevance 6/10Novelty 5/10Timing: after-hours filing

Background

SEC Form 4 filing discloses insider transactions, a primary source of corporate insider activity.

Company-level read

Ticker impact

$HCABearishMedium confidence
Context

Form 4 shows SVP & Chief Nurse Executive sold 3,500 shares for $1.77M, reducing her stake to 13,426 shares.

Expected impact

likely modest downward pressure as market prices in the insider sell

Evidence & confidence

The sale size is notable for an executive but not large enough to drive a major move; investors may view it as a slight negative signal.

Market effects

Minimal impact on healthcare sector; isolated insider transaction.

No broader regional effect.

Limited to HCA investors.

Counterpoint

The sale could be unrelated to confidence and merely personal diversification, so the stock may remain unaffected.

Key entities

  • Rossitto Erica

    SVP & Chief Nurse Executive at HCA Healthcare, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$CNCMed

Health insurers, hospitals rally after sweeping midterm win for Democrats

Shares of Medicaid-focused health insurers (Centene, Elevance, Molina) and hospital operators (HCA, Tenet, Universal) rose after Democrats won the midterms, raising hopes for sector-friendly policies. Analysts expect delays in Trump's OBBBA, easing pressure on Medicaid and ACA insurers, and potential extensions of enhanced subsidies. Year-to-date gains vary among companies.

$TSLAHighAI 8/10

Tesla, SpaceX And AI Stocks Slide After Democrats Take Congress

Stock futures rose premarket after Democrats took control of Congress. Renewable energy and healthcare stocks gained, while AI-linked and Texas-based companies like Tesla (TSLA) and SpaceX fell. Oracle (ORCL) and Nvidia (NVDA) also declined on data center concerns. Trump Media & Technology Group (DJT) shares dropped 11%.